Showing results (71-80 of 249) with videos related to
Sort By:
Pageof 25
Advances in Experimental Medicine and Biology|May 30, 2019
HLA Class-II Expression in Human TumorsFederico GarridoCancer Biology & Therapy|January 17, 2004
Identification of novel survivin-derived CTL epitopesSine Reker, Anders Meier, Lars Holten-Andersen, et al.Ecancermedicalscience|December 21, 2016
Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisationLinda Cairns, Sandrine Aspeslagh, Andrea Anichini, et al.Oncoimmunology|February 26, 2024
Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cellsHannah Jorinde Glöckner, Evelina Martinenaite, Thomas Landkildehus Lisle, et al.Cancer Immunology, Immunotherapy : CII|October 29, 2010
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donorsRikke Sick Andersen, Rikke Bæk Sørensen, Cathrin Ritter, et al.The Journal of Investigative Dermatology|February 13, 2009
Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56Rikke Baek Sørensen, Mikkel Faurschou, Lone Troelsen, et al.Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.Journal of Leukocyte Biology|October 18, 2024
MerTK signaling in human primary T cells modulates memory potential and improves recall responseAnne Rahbech, Annina Kurzay, Sara Fresnillo Saló, et al.Oncoimmunology|December 25, 2012
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transferMarco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.Blood|June 29, 2011
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-αCaroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, et al.Pageof 25